| 中文名 | RAD51 Inhibitor B02 |
| 英文名 | RAD51 Inhibitor B02 |
| 别名 | 化合物B02 RAD51抑制剂B02 RAD51 INHIBITOR B02游离态 RAD51抑制剂(RAD51 INHIBITOR B02) |
| 英文别名 | B02 BO2 CS-2461 RAD51 INHIBITOR B02 RAD51 Inhibitor B02 (E)-3-benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone 4(3H)-Quinazolinone, 3-(phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]- |
| CAS | 1290541-46-6 |
| 化学式 | C22H17N3O |
| 分子量 | 339.39 |
| 熔点 | 174-175o C |
| 溶解度 | DMSO: ≥ 5 mg/mL |
| 存储条件 | 2-8°C |
| 稳定性 | 吸湿性 |
| 外观 | 粉末 |
| 颜色 | faint yellow to dark yellow |
| 体外研究 | RAD51 Inhibitor B02 specifically inhibits human RAD51 (IC 50 =27.4 μM), but not its E. coli homologue RecA (IC 50 >250 μM). The combination of B02 with cisplatin has the strongest killing effect on the human breast cancer cells MDA-MB-231. |
| 体内研究 | B02 significantly enhances the therapeutic effect of cisplatin on tumor cells in vivo . B02 is tolerated by mice at doses up to 50 mg/kg without obvious body weight loss. No inhibition of tumor growth is observed on mice solely treated by B02. Mice treated with 4 mg/kg cisplatin, however, shows a 33% inhibition of tumor growth. Finally, mice treated with 50 mg/kg B02 and 4 mg/kg cisplatin shows a 66% inhibition of tumor growth. |
| 危险品标志 | Xn - 有害物品![]() |
| 风险术语 | 22 - 吞食有害。 |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.946 ml | 14.732 ml | 29.465 ml |
| 5 mM | 0.589 ml | 2.946 ml | 5.893 ml |
| 10 mM | 0.295 ml | 1.473 ml | 2.946 ml |
| 5 mM | 0.059 ml | 0.295 ml | 0.589 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!